Marketing-authorisation holder · Singapore
Roche Singapore Pte. Ltd.
61 medicines in 1 country, as authorisation holder.
Loading your page…
Marketing-authorisation holder · Singapore
61 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 61
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Actemra 162mg Solution for Injection in Pre-filled Syringe 162mg/0.9ml162 mg/0.9 mL · Injection, solution | Tocilizumab | Singapore | Authorised | 2015 |
| Actemra Concentrate for Solution for Infusion 20mg/ml20mg/ml · Infusion, solution concentrate | Tocilizumab | Singapore | Authorised | 2009 |
| ALECENSA HARD CAPSULE 150MG150 mg · Capsule | Alectinib | Singapore | Authorised | 2017 |
| Avastin Concentrate for Solution for Infusion 100mg/4ml25mg · Infusion, solution concentrate | Bevacizumab | Singapore | Authorised | 2005 |
| Avastin Concentrate for Solution for Infusion 400mg/16ml400mg · Infusion, solution concentrate | Bevacizumab | Singapore | Authorised | 2012 |
| CELLCEPT CAPSULE 250 mg250 mg · Capsule | Mycophenolate mofetil | Singapore | Authorised | 1997 |
| CELLCEPT FOR I.V. INFUSION 500 mg/vial500 mg/vial · Injection, powder, for solution | Mycophenolate mofetil | Singapore | Authorised | 2000 |
| CELLCEPT TABLET 500 mg500 mg · Tablet, film coated | Mycophenolate mofetil | Singapore | Authorised | 1998 |
| COLUMVI CONCENTRATE FOR SOLUTION FOR INFUSION 1MG/ML1 mg/ml · Infusion, solution concentrate | Glofitamab | Singapore | Authorised | 2024 |
| COTELLIC FILM-COATED TABLET 20 MG20mg · Tablet, film coated | Cobimetinib | Singapore | Authorised | 2017 |
| ENSPRYNG SOLUTION FOR INJECTION IN PREFILLED SYRINGE 120MG/1ML120 mg/ml · Injection, solution | Satralizumab | Singapore | Authorised | 2021 |
| ESBRIET FILM COATED TABLET 267MG267.000 mg · Tablet, film coated | Pirfenidone | Singapore | Authorised | 2018 |
| ESBRIET FILM COATED TABLET 801MG801.000 mg · Tablet, film coated | Pirfenidone | Singapore | Authorised | 2018 |
| EVRYSDI FILM-COATED TABLET 5MG5.000 mg · Tablet, film coated | Risdiplam | Singapore | Authorised | 2026 |
| EVRYSDI POWDER FOR ORAL SOLUTION 0.75 MG/ML60 mg · Powder, for solution | Risdiplam | Singapore | Authorised | 2021 |
| GAZYVA CONCENTRATE FOR SOLUTION FOR INFUSION 1000MG/40ML1000 mg/40 mL · Infusion, solution concentrate | Obinutuzumab | Singapore | Authorised | 2015 |
| HEMLIBRA SOLUTION FOR INJECTION 150MG/ML150mg/ml · Injection, solution | Emicizumab | Singapore | Authorised | 2018 |
| HEMLIBRA SOLUTION FOR INJECTION 30MG/ML30 mg/mL · Injection, solution | Emicizumab | Singapore | Authorised | 2018 |
| HERCEPTIN POWDER FOR INJECTION 440 mg/vial440 mg/vial · Injection, powder, for solution | Trastuzumab | Singapore | Authorised | 1999 |
| HERCEPTIN SOLUTION FOR INJECTION 600MG/5ML600mg · Injection, solution | Trastuzumab | Singapore | Authorised | 2015 |
| ITOVEBI FILM COATED TABLETS 3MG3mg · Tablet, film coated | Inavolisib | Singapore | Authorised | 2025 |
| ITOVEBI FILM COATED TABLETS 9 MG9mg · Tablet, film coated | Inavolisib | Singapore | Authorised | 2025 |
| KADCYLA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL100 mg/vial · Injection, powder, for solution | Trastuzumab emtansine | Singapore | Authorised | 2014 |
| KADCYLA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 160MG/VIAL160 mg/vial · Injection, powder, for solution | Trastuzumab emtansine | Singapore | Authorised | 2014 |
| LUNSUMIO CONCENTRATE FOR SOLUTION FOR INFUSION 1MG/ML1 mg/ml · Infusion, solution concentrate | Mosunetuzumab | Singapore | Authorised | 2024 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Singapore | 61 | 61 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.